NTRB nutriband.com Year-over-year earnings per share growth for the last twelve months

Public company logo of nutriband.com (NTRB)

Risks for Nutriband Inc. (NTRB) are linked to the dependency on regulatory approval for overdose patches, which would enable the company to exercise pricing power over government agencies. The quarterly EPS growth rate serves as a stability indicator, with the current level standing at 96.10. Revenues are based on the commercialization of pain drug delivery systems, although the investment stage for testing is temporarily increasing unit costs.

NTRB: Nutriband Inc Quarterly EPS earnings growth 07/04/2022 - 11/17/2026

nutriband.com (NTRB) - metric breakdowns and financial figures

- market value and analyst target forecast:
Analysis of all company metrics:Nutriband Inc. - NTRB
Manufactured product of Nutriband Inc.

Quarterly EPS growth measures the dynamics of net profit per share relative to the previous period, allowing for an assessment of business scaling efficiency and fundamental capital stability. The implementation of ESG standards and the optimization of polymer recycling at Nutriband Inc. (NTRB) directly impact operating expenses, which is reflected in the quarterly EPS growth, confirming the company's ability to generate profit through environmental modernization.

Direct competitors

Indivior Corp (INDV) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share growth for the last 12 months Collegium Pharmaceutical Inc|CRON (thecronosgroup.com) - Quarterly EPS earnings growth|Quarterly EPS earnings growth canopygrowth.com|Quarterly EPS earnings growth HITI|ACB (Aurora Cannabis, Inc.) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth ACHV (Achieve Life Sciences, Inc)|Skye Bioscience (SKYE) - Earnings per share growth in annualized terms for the last twelve months|Anebulo Pharmaceuticals - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months InterCure|Nasus Pharma Ltd (NSRX) - Year-over-year earnings per share growth for the last twelve months|India Globalization Capital - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months MIRA Pharma|FLGC: Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months IMC (IMCC)|ADIL: Year-over-year net earnings per share trend for the last twelve months|Quarterly EPS earnings growth ARTL (Artelo)|Year-over-year earnings per one share growth for the last 12 months ENSC|Titan Pharmaceuticals - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Greenlane Holdings|inmedpharma.com (INM) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last 12 months AKAN|Year-over-year earnings per share growth for the last twelve months Enveric Corp|Earnings per share growth in annualized terms for the last twelve months brightgreen.us BGXX|Year-over-year net earnings per share growth for the last 12 months HPCO (Hempacco Co Inc.)